Skip to content
Screener

Cytek Biosciences, Inc. CTKB Balance Sheet Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$66.81M-28.4%$73.85M-2.2%$31.81M-66.6%$28.98M-70.6%$93.28M-42.5%
$59.19M+4.5%$49.7M-11.6%$51.9M-5.7%$62.51M+3.2%$56.63M+7.6%
$52.37M+1.4%$52.25M+5.6%$49.79M+9.8%$48.43M+10.3%$51.65M+10.4%
$378.94M-2.5%$377.93M-1.3%$379.3M-0.3%$392M-1.1%$388.49M-0.4%
$20.61M+14.2%$20.8M+13.3%$20.47M+14.8%$18.01M+0.3%$18.05M-2.5%
$16.69M0.0%$16.69M-0.1%$16.69M+0.1%$16.7M+0.2%$16.7M+3.2%
$14.03M-20.6%$14.87M-20.1%$15.7M-19.2%$16.82M-16.4%$17.68M-13.7%
$446.15M-9.9%$446.93M-9.4%$449.11M-6.9%$461.54M-7.6%$494.92M+0.8%
$4.89M-36.0%$8.41M+22.7%$6.74M+7.9%$6.41M+15.9%$7.63M+41.6%
$18.74M+14.9%$18.06M+8.6%$30.03M+91.1%$28.5M+77.1%$16.32M+10.3%
$84.95M+13.0%$84.34M+15.1%$80.94M+19.6%$77.8M+15.0%$75.21M+19.8%
$99K-84.9%$246K-68.9%$386K-58.0%$525K-50.0%$655K-47.0%
$124.79M+7.3%$124.98M+8.0%$121.47M+18.0%$119.8M+15.5%$116.35M+10.0%
$131K+2.3%$130K+2.4%$1B+781,150%$129K0.0%$128K-1.5%
-$138.86M-141%-$132.76M-154%-$120.6M-159%-$101.74M-189%-$57.66M-28.6%
$321.35M-15.1%$321.95M-14.7%$327.64M-13.7%$341.74M-13.6%$378.57M-1.8%
$446.15M-9.9%$446.93M-9.4%$449.11M-6.9%$461.54M-7.6%$494.92M+0.8%

FAQ

What are Cytek Biosciences, Inc.'s total assets?
Cytek Biosciences, Inc. (CTKB) holds $446.1M in total assets, down 9.8% year over year.
How much debt does Cytek Biosciences, Inc. have?
Cytek Biosciences, Inc. carries $16.3M in total debt against $321.4M of shareholders' equity, a debt-to-equity ratio of 0.05.
How much cash does Cytek Biosciences, Inc. have?
Cytek Biosciences, Inc. holds $66.8M in cash and equivalents.
Can Cytek Biosciences, Inc. cover its short-term obligations?
Its current ratio is 4.46 — current assets exceed current liabilities.
Where does Cytek Biosciences, Inc.'s balance sheet data come from?
Every line is extracted from Cytek Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.